Consensus DexCom, Inc. Sao Paulo

Stocks

D1EX34

BRD1EXBDR004

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 09:01:00 2026-10-19 EDT			5-day change	1st Jan Change
8.570 ^BRL	-7.95%		-2.06%	+14.42%

10-16	HEALTH ROUNDS-Glucose monitoring devices for type 2 diabetes benefit even those not on insulin	RE
10-14	DexCom, Inc. Announces Publication Of CONNECT Study Results For Dexcom G7 In The New England Journal Of Medicine	CI

4d9.QlgA1jQbv1j_lQNAtHYXiL7lhELIsPMQ5-UdHegIbG8.LhBGuwdV5y61yjEX4htNy-jS7zOg_rh0kKJac4tLKy0MFjSmeVPTLc_3Ug~691e8dea32a4ef950b2fd9e443b1c391

Analysts' recommendations: DexCom, Inc.

10-13	Mizuho Adjusts Price Target on DexCom to $100 From $95	MT
10-12	BTIG Adjusts Price Target on DexCom to $96 From $90	MT
10-07	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
08-03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
08-03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
07-31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
07-31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
07-31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
07-31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
07-31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
07-31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
07-31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
07-31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
07-31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
07-31	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
07-31	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
07-31	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
07-31	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
07-31	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
07-31	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
07-31	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+15.09%
	MEDTRONIC PLC					+10.41%
	STRYKER CORPORATION					+23.06%
	ESSILORLUXOTTICA					+43.42%
	CENCORA, INC.					+7.85%
	HOYA CORPORATION					+16.96%
	BECTON, DICKINSON AND COMPANY					+1.21%
	IDEXX LABORATORIES, INC.					+25.9%
	DEXCOM, INC.					+12.11%
	Average					+17.33%
	Weighted average by Cap.					+17.67%